These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20472152)

  • 1. Alteplase for ischaemic stroke--much sooner is much better.
    Saver JL; Levine SR
    Lancet; 2010 May; 375(9727):1667-8. PubMed ID: 20472152
    [No Abstract]   [Full Text] [Related]  

  • 2. Questions about authorisation of alteplase for ischaemic stroke.
    Shinton R
    Lancet; 2014 Aug; 384(9944):659-60. PubMed ID: 25152265
    [No Abstract]   [Full Text] [Related]  

  • 3. A panoramic, practice-based view of intravenous alteplase 3-4.5 h after stroke.
    Kasner SE; Levine SR
    Lancet Neurol; 2010 Sep; 9(9):843-5. PubMed ID: 20667791
    [No Abstract]   [Full Text] [Related]  

  • 4. Alteplase for the treatment of acute ischaemic stroke: a single technology appraisal.
    Jones ML; Holmes M
    Health Technol Assess; 2009 Sep; 13 Suppl 2():15-21. PubMed ID: 19804685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should more patients with acute ischaemic stroke receive thrombolytic treatment?
    Wardlaw JM; Sandercock PA; Murray V
    BMJ; 2009 Nov; 339():b4584. PubMed ID: 19906748
    [No Abstract]   [Full Text] [Related]  

  • 6. Alteplase for acute stroke revisited: the first 10 years.
    Lyden PD; Lees KR; Davis SM
    Lancet Neurol; 2006 Sep; 5(9):722-4. PubMed ID: 16914399
    [No Abstract]   [Full Text] [Related]  

  • 7. Alteplase and ischaemic stroke: have new reviews of old data helped?
    Lindley RI; Wardlaw JM; Sandercock PA
    Lancet Neurol; 2005 Apr; 4(4):249-53. PubMed ID: 15778104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous recombinant tissue plasminogen activator administered after 3 h following onset of ischaemic stroke: a metaanalysis.
    Maiser SJ; Georgiadis AL; Suri MF; Vazquez G; Lakshminarayan K; Qureshi AI
    Int J Stroke; 2011 Feb; 6(1):25-32. PubMed ID: 21205237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid EEG changes indicate reperfusion after tissue plasminogen activator injection in acute ischaemic stroke.
    Finnigan SP; Rose SE; Chalk JB
    Clin Neurophysiol; 2006 Oct; 117(10):2338-9. PubMed ID: 16926108
    [No Abstract]   [Full Text] [Related]  

  • 10. Alteplase for stroke. Uncertainty remains about efficacy.
    Mann H
    BMJ; 2002 Jun; 324(7353):1581; author reply 1581. PubMed ID: 12089100
    [No Abstract]   [Full Text] [Related]  

  • 11. tPA after stroke: the sooner the better: clinical benefit is gone by six hours.
    Kennedy MS; Ferri RS; Sofer D
    Am J Nurs; 2004 Jun; 104(6):18. PubMed ID: 15187596
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravenous alteplase for ischaemic stroke.
    Albers GW; Olivot JM
    Lancet; 2007 Jan; 369(9558):249-50. PubMed ID: 17258646
    [No Abstract]   [Full Text] [Related]  

  • 13. Alteplase: new indication. Inadequately assessed in ischaemic stroke.
    Prescrire Int; 2004 Aug; 13(72):127-31. PubMed ID: 15532135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of alteplase in childhood arterial ischaemic stroke: a multicentre, observational, cohort study.
    Amlie-Lefond C; deVeber G; Chan AK; Benedict S; Bernard T; Carpenter J; Dowling MM; Fullerton H; Hovinga C; Kirton A; Lo W; Zamel K; Ichord R;
    Lancet Neurol; 2009 Jun; 8(6):530-6. PubMed ID: 19423401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravenous thrombolysis in the treatment of acute ischaemic stroke: 3, 4.5, or 6 hours?].
    Kwieciński H
    Neurol Neurochir Pol; 2009; 43(3):213-5. PubMed ID: 19618303
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomised trials of endovascular treatment of stroke are needed.
    Ciccone A; Sterzi R
    Lancet Neurol; 2010 Jan; 9(1):30; author reply 31-2. PubMed ID: 20083033
    [No Abstract]   [Full Text] [Related]  

  • 17. Further randomized controlled trials of tissue plasminogen activator within 3 hours are required.
    Lindley RI
    Stroke; 2001 Nov; 32(11):2708-9. PubMed ID: 11692040
    [No Abstract]   [Full Text] [Related]  

  • 18. Alteplase not yet proven for acute ischaemic stroke.
    Bath P
    Lancet; 1998 Oct; 352(9136):1238-9. PubMed ID: 9788448
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased benefit of alteplase in patients with ischemic stroke and a high body temperature.
    de Ridder I; den Hertog H; van Gemert M; Dippel D; van der Worp B;
    Cerebrovasc Dis; 2013; 35(1):60-3. PubMed ID: 23428998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolytic therapy with alteplase for ischaemic stroke.
    Drug Ther Bull; 2009 Feb; 47(2):14-8. PubMed ID: 19193701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.